Anti-cancer pharmaceutical compositions and methods for treating patients with cancer
AssigneeDaiichi Sankyo Company, Limited
InventorsKosaku Fujiwara, Naomi Shimazaki
Life of this patent
Estimating the term…
Abstract
Method of treating persons having carcinoma, sarcoma or hematopoietic cancer by administering (i) a compound of the formula (I) and (ii) an epidermal growth factor receptor (EGFR) inhibitor, a vascular endothelial growth factor receptor (VEGFR) inhibitor and pharmaceutical compositions for use in said method. A method for treating gastric cancer, colon cancer, lung cancer, breast cancer, pancreas cancer, kidney cancer, prostate cancer, medulloblastoma, rhabdomyosarcoma, Ewing sarcoma, liposarcoma, multiple myeloma and leukemia by administering a compound of the formula (I).
Claims2
An anti-cancer pharmaceutical composition for the treatment of lung cancer, comprising (a) an effective amount of erlotinib;
- and (b) an effective amount of 5-(4-(6-(4-amino-3,5-dimethyl-phenoxy)-1-methyl-1H-benzimidazol-2-ylmethoxy)-benzyl)-thiazolidine-2,4-dione.dihydrochloride;
- as active ingredients.
A method of treating a person having lung cancer comprising administering to said person (a) an effective amount of erlotinib and (b) an effective amount of 5-(4-(6-(4-amino-3,5-dimethyl-phenoxy)-1-methyl-1H-benzimidazol-2-ylmethoxy)-benzyl)-thiazolidine-2,4-dione.dihydrochloride.
Dependencies are inferred from the claim text.